NOC vs TVTX · P/E 17, rev $20.76B vs rev $296.8M
Northrop Grumman Corporation (NOC) versus Travere Therapeutics Inc (TVTX) — a side-by-side from cached financials, not a winner call.
Northrop Grumman Corporation (NOC) is a aerospace & defense company listed on NYSE.
Travere Therapeutics Inc (TVTX) is a biotechnology company listed on US.
Latest reported NOC revenue for 2026-06-30 was $20.76B. Net income was $1.97B. NOC currently screens at market cap $78.14B and trailing P/E 17.2.
Latest reported TVTX revenue for 2026-06-30 was $296.8M. Net income was -$71.9M. TVTX currently screens at market cap $1.33B.
NOC currently screens at market cap $78.14B and trailing P/E 17.2. TVTX currently screens at market cap $1.33B.
Not investment advice. Open the NOC and TVTX stock pages for the full models.
Not investment advice.